The results of a new clinical trial have overturned the “wait and see” approach that cardiologists have long favored for symptom-free patients.
Related Posts
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits…
Voters in Red and Blue States Repudiate Lenient Drug Policies
Californians voted for tougher penalties for dealers. Florida, North Dakota and South Dakota rejected proposals to legalize marijuana. Massachusetts denied…
Cannabis Tops Alcohol as Americans’ Daily Drug of Choice
For the first time on record, cannabis has outpaced alcohol as the daily drug of choice for Americans. In 2022…